Skip to Content
AP National Business

Sunesis: Q4 Earnings Snapshot

KION
By
Published 1:26 PM

CARDIFF, Calif. (AP) — CARDIFF, Calif. (AP) — Viracta Therapeutics, Inc. (VIRX) on Monday reported a loss of $10.3 million in its fourth quarter.

On a per-share basis, the Cardiff, California-based company said it had a loss of 27 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.

For the year, the company reported a loss of $49.2 million, or $1.30 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIRX at https://www.zacks.com/ap/VIRX

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

Related Articles

BE PART OF THE CONVERSATION

KION 46 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content